Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01.
Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01.
复制标题
来自表达HLA-A*32:01的未用药供体的替考拉宁特异性T细胞的表征。
DOI:
10.1021/acs.chemrestox.1c00425
复制
发表时间:
2022-02-21
影响因子:
4.1
通讯作者:
Naisbitt, Dean J.
中科院分区:
文献类型:
--
作者:
Gardner, Joshua;Ogese, Monday;Betts, Catherine J.;Pirmohamed, Munir;Naisbitt, Dean J.
Teicoplanin is a glycopeptide antibiotic deployed to combat Gram-positive bacterial infection and has recently been associated with development of adverse drug reactions, particularly following previous exposure to vancomycin. In this study, we generated teicoplanin-specific monoclonal T-cell populations from healthy volunteers expressing HLA-A*32:01 and defined pathways of T-cell activation and HLA allele restriction. Teicoplanin-responsive T-cells were CD8+, HLA class I-restricted, and cross-reacted with the lipoglycopeptide daptomycin in proliferation and cytokine/cytolytic molecule (granzyme B, Perforin, and FasL) release assays. These data show that teicoplanin activates T-cells, which may play a role in the pathogenesis of teicoplanin-induced adverse events, in HLA-A*32:01 positive donors.
登录
查看更多内容
DOI:
10.1093/toxsci/kfab084
发表时间:
2021-08-30
期刊:
Toxicological sciences : an official journal of the Society of Toxicology
影响因子:
--
作者:
Ogese MO;Lister A;Gardner J;Meng X;Alfirevic A;Pirmohamed M;Park BK;Naisbitt DJ
通讯作者:
Naisbitt DJ
影响因子:
14.2
作者:
Konvinse, Katherine C.;Trubiano, Jason A.;Phillips, Elizabeth J.
通讯作者:
Phillips, Elizabeth J.
影响因子:
10.5
作者:
Pavlos R;Mallal S;Ostrov D;Buus S;Metushi I;Peters B;Phillips E
通讯作者:
Phillips E
影响因子:
4.5
作者:
Kwon, Hyouk-Soo;Chang, Yoon-Seok;Min, Kyung-Up
通讯作者:
Min, Kyung-Up
影响因子:
10.3
作者:
Choquet-Kastylevsky, G;Intrator, L;Roujeau, JC
通讯作者:
Roujeau, JC